Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays
about
Thermostable DNA polymerase from a viral metagenome is a potent RT-PCR enzymeComparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5Broad Differences between the COBAS Ampliprep Total Nucleic Acid Isolation-COBAS TaqMan 48 Hepatitis C Virus (HCV) and COBAS HCV Monitor v2.0 Assays for Quantification of Serum HCV RNA of Non-1 GenotypesMultilaboratory Comparison of Hepatitis C Virus Viral Load AssaysComparison of the Abbott 7000 and Bayer 340 Systems for Measurement of Hepatitis C Virus LoadMulticenter Trials Need To Use the Same Assay for Hepatitis C Virus Viral Load DeterminationPerformance Characteristics of a Quantitative Hepatitis C Virus RNA Assay Using COBAS AmpliPrep Total Nucleic Acid Isolation and COBAS TaqMan Hepatitis C Virus Analyte-Specific ReagentRNase-Resistant Virus-Like Particles Containing Long Chimeric RNA Sequences Produced by Two-Plasmid Coexpression SystemA Novel Diagnostic Target in the Hepatitis C Virus GenomeAnomalous Quantitation Standard Growth Curves in a Laboratory-Developed Hepatitis C Virus (HCV) RNA Quantification Assay Using the TaqMan HCV Analyte-Specific ReagentDetection and Quantification of Hepatitis C Virus (HCV) by MultiCode-RTx Real-Time PCR Targeting the HCV 3' Untranslated RegionEvaluation of the Abbott Investigational Use Only RealTime Hepatitis C Virus (HCV) Assay and Comparison to the Roche TaqMan HCV Analyte-Specific Reagent AssayInterpretation of real-time PCR results for hepatitis C virus RNA when viral load is below quantification limitsUse of duplex mutation primers for real-time PCR quantification of hepatitis C virus RNA in serum.Preparation of His-tagged armored RNA phage particles as a control for real-time reverse transcription-PCR detection of severe acute respiratory syndrome coronavirus.A novel method to produce armored double-stranded DNA by encapsulation of MS2 viral capsids.Comparisons of three automated systems for genomic DNA extraction in a clinical diagnostic laboratory."12 weeks' stopping rule" in the treatment of genotype 1 chronic hepatitis C: two prognostic categories under the same label?
P2860
Q21089871-BC2DF5AC-29A5-4B74-9B95-10A68E08C1D6Q27473038-756EBB25-A2CB-4FA6-A4E0-9A38D446C9BCQ27473157-15E517EF-7536-4100-96A9-DDDE90757E85Q27473252-1E583940-8F60-44D2-B0B4-10AA205144C3Q27481437-31AA0700-BAB1-4468-BCE3-90EA33B6ACAAQ27484906-7D798D93-60E8-4081-B25D-738EFD420B08Q27485460-14E02449-1B8B-4D72-833B-1E371CAB04ECQ27486111-599629CD-813C-49C3-9601-34766B2C1280Q27487878-B2DBF43D-2787-4C23-9F1E-F86EC53F3D04Q27488880-78113BA2-32F6-4F76-98BE-A07E366BC407Q27489128-AB1F0872-85FC-47CC-8AFE-BF2BB87D7763Q27489512-9E00F82E-2925-48BD-B888-AB9866AFD995Q34741602-07C03117-E3A8-4674-B6BF-C02725F04EF4Q35540195-1E314FE9-42EE-4631-82FC-13D07BAE51EBQ38479169-6AC3DBE0-1E72-4878-9EA5-C00299979FDBQ41733472-3A0F04EE-47DB-4843-9E30-F33AB164BDB3Q42945200-48FAF9DB-7B19-42A1-B2B2-0C5B426204DAQ42983924-0748CB89-E8A1-492E-B3C3-B2340C0CF283
P2860
Evaluation of the COBAS Hepatitis C Virus (HCV) TaqMan Analyte-Specific Reagent Assay and Comparison to the COBAS Amplicor HCV Monitor V2.0 and Versant HCV bDNA 3.0 Assays
description
2005 nî lūn-bûn
@nan
2005 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@ast
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@en
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@nl
type
label
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@ast
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@en
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@nl
prefLabel
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@ast
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@en
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 Assays
@nl
P2093
P2860
P1476
Evaluation of the COBAS Hepati ...... nd Versant HCV bDNA 3.0 assays
@en
P2093
David R Hillyard
Edward R Ashwood
Sheri M Williams
P2860
P304
P356
10.1128/JCM.43.5.2133-2140.2005
P407
P577
2005-05-01T00:00:00Z